- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02664584
The Trinity, Ulster and Department of Agriculture Cohort Study (TUDA)
Background:
Cardiovascular disease (CVD), osteoporosis and dementia are chronic diseases of ageing that impact adversely on the lives of those affected and have major health, social and economic consequences. A number of factors are considered to be implicated in these diseases, ranging from the more established factors to those that are less well recognised. Lifestyle factors such as diet, body weight, smoking, physical activity and years of education are acknowledged as risk factors for the development of these chronic diseases of aging. Emerging research suggests that elevated homocysteine and/or sub-optimal status of the metabolically related B-vitamins (folate, vitamin B12, B6 and riboflavin) may be associated with a higher risk of age-related disease. The interplay between relevant genetic and nutrient factors (gene-nutrient interactions) is considered to be highly relevant in the development (and prevention) of chronic diseases of ageing, however this relatively new area of research is as yet poorly understood. The collection of clinical, lifestyle, nutritional and genetic data on large numbers of patients would permit the investigation of those nutrients which interact with specific genes to increase the likelihood of a person developing chronic diseases of ageing.
Aim:
The aim of the TUDA study is to collect detailed clinical, lifestyle, dietary, genetic and biochemical data to investigate gene-nutrient interactions (particularly from the perspective of the B-vitamins and vitamin D/calcium) in the development of CVD, osteoporosis and dementia by studying older adults exhibiting the early stages of these common diseases, namely hypertension, low bone mineral density, and early memory loss, respectively.
Secondary aim (follow up TUDA investigation):
The aim of this longitudinal investigation is to re-assess clinical, nutritional, genetic and biochemical factors in relation to the progression of disease outcomes in TUDA study participants, in subsequent years after initial investigation.
Study design:
A total of 6000 non-institutionalised older Irish people aged over 60 years with early predictors of either dementia, stroke and osteoporosis (namely early memory loss, high blood pressure and low bone mineral density, respectively) recruited from three centres (St James's Hospital Dublin, Ulster University Coleraine and The Clinical Translational Research and Innovation Centre (C-TRIC), Londonderry) across Ireland. Non-fasting blood samples were collected from all subjects and routine blood biochemistry profiles and biomarkers of relevance to B vitamin and vitamin D status were measured. Supplement use was recorded and a targeted food frequency questionnaire was used to record dietary intakes of specific vitamins of interest (folate, B12, B6, riboflavin and D) from major food sources, particularly fortified foods. Physiological function tests including blood pressure, bone health (DXA scans) and cognitive function tests and anthropometric measures were also taken.
Studienübersicht
Status
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
Dublin8
-
Dublin, Dublin8, Irland
- St James's Hospital
-
-
-
-
-
Londonderry, Vereinigtes Königreich, BT47 6SB
- Clinical Translational Research and Innovation Centre (C-TRIC), Altnagelvin Hospital
-
-
Londonderry
-
Coleraine, Londonderry, Vereinigtes Königreich, BT52 1SA
- Human Intervention Studies Unit, Ulster University
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- >60 years of age
Exclusion Criteria:
- <60 years of age
- Born outside the island of Ireland
- Severe dementia
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
|---|
|
Cross-sectional cohort
Cohort who took part in the cross-sectional study (n=5186)
|
|
Cross-sectional cohort + follow-up
Cohort who took part in both the cross-sectional and follow-up study (planned n=500 (on-going))
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Blood pressure
Zeitfenster: 10 years
|
10 years
|
|
|
Bone health (DXA)
Zeitfenster: 10 years
|
Dual energy x ray absorptiometry (DXA) scan
|
10 years
|
|
Cognitive function 1 (MMSE)
Zeitfenster: 10 years
|
Mini-Mental State Examination (MMSE)
|
10 years
|
|
Cognitive function 2 (FAB)
Zeitfenster: 10 years
|
Frontal Assessment Battery (FAB)
|
10 years
|
|
Cognitive function 3 (RBANS)
Zeitfenster: 10 years
|
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
|
10 years
|
|
Anxiety (HADS)
Zeitfenster: 10 years
|
Hospital Anxiety and Depression Scale (HADS)
|
10 years
|
|
Depression (CES-D)
Zeitfenster: 10 years
|
Center for Epidemiologic Studies Depression Scale (CES-D)
|
10 years
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Weight
Zeitfenster: 10 years
|
10 years
|
|
|
Routine biochemical markers
Zeitfenster: 10 years
|
Measured in blood
|
10 years
|
|
Vitamin biomarkers
Zeitfenster: 10 years
|
Measured in blood
|
10 years
|
|
Single nucleotide polymorphisms
Zeitfenster: 10 years
|
Measured in DNA sample
|
10 years
|
|
Measures of mobility (TUG)
Zeitfenster: 10 years
|
Timed Up and Go (TUG)
|
10 years
|
|
Measures of muscle strength
Zeitfenster: 10 years
|
Hand grip strength (dynamometer)
|
10 years
|
|
Bone turnover markers
Zeitfenster: 10 years
|
Measured in blood
|
10 years
|
Mitarbeiter und Ermittler
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
- Psychische Störungen
- Stoffwechselerkrankungen
- Erkrankungen des Gehirns
- Erkrankungen des zentralen Nervensystems
- Erkrankungen des Nervensystems
- Neurokognitive Störungen
- Erkrankungen des Bewegungsapparates
- Neurodegenerative Krankheiten
- Knochenerkrankungen
- Demenz
- Tauopathien
- Knochenerkrankungen, Stoffwechsel
- Herz-Kreislauf-Erkrankungen
- Alzheimer Erkrankung
- Osteoporose
Andere Studien-ID-Nummern
- 08NIR03/113
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Hypertonie
-
Xijing HospitalAnmeldung auf EinladungPropranolol | Carvedilol | Rezidivblutung bei portaler Hypertension bei LeberzirrhoseChina
-
Instituto Dante Pazzanese de CardiologiaServierRekrutierungHypertonie | Hoher Blutdruck | Apparent Resistant HypertensionBrasilien
-
Joint Shantou International Eye Center of Shantou...AbgeschlossenPrimäres Engwinkelglaukom | Akutes okuläres Hypertonie-Glaukom | Intraokuläre HypertensionChina
-
Fondazione Policlinico Universitario Agostino Gemelli...Noch keine RekrutierungPortaler Bluthochdruck | Zirrhose, Leber | Gastroösophageale Varizen | Klinisch signifikante portale Hypertension (CSPH)Italien
-
Nantes University HospitalBeendetZirrhotischer Patient mit Verdacht auf portale Hypertension und im Rahmen eines OV-ScreeningsFrankreich